Skip to main content
Roham Zamanian, MD, Pulmonology, Stanford, CA

Roham T Zamanian MD

Critical Care Medicine, Pleural Disease


Assistant Professor, Medicine - Pulmonary & Critical Care Medicine, Stanford University Medical Center

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Zamanian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
  • University of California (Irvine)
    University of California (Irvine)Residency, Internal Medicine, 1999 - 2002
  • University of California, Irvine, School of Medicine
    University of California, Irvine, School of MedicineClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - 2025
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Pulmonary Vascular Fellowship Training to Promote Excellence in PH Clinical Care: The Stanford PerspectiveSeptember 2020

Press Mentions

  • Tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat
    Tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of TiprelestatJanuary 8th, 2025
  • Hemodynamic Trajectories and Outcomes in Patients with Pulmonary Arterial Hypertension
    Hemodynamic Trajectories and Outcomes in Patients with Pulmonary Arterial HypertensionDecember 6th, 2020
  • Inhaled Nitric Oxide Explored for COVID-19 Oxygenation
    Inhaled Nitric Oxide Explored for COVID-19 OxygenationMay 13th, 2020
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: